A unified evaluation of differential vaccine efficacy
From MaRDI portal
Publication:6047741
DOI10.1111/BIOM.13211zbMATH Open1520.62204OpenAlexW2998489773WikidataQ92202559 ScholiaQ92202559MaRDI QIDQ6047741FDOQ6047741
Authors: Erin E. Gabriel, Michael C. Sachs, Dean A. Follmann 
Publication date: 9 October 2023
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/biom.13211
Recommendations
- Leaky vaccines protect highly exposed recipients at a lower rate: implications for vaccine efficacy estimation and sieve analysis
- Sieve analysis using the number of infecting pathogens
- Assessing trends in vaccine efficacy by pathogen genetic distance
- Design and analysis of vaccine studies
- Hypotheses tests of strain-specific vaccine efficacy adjusted for covariate effects
Cites Work
- Title not available (Why is that?)
- Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- All of Nonparametric Statistics
- Comparing biomarkers as principal surrogate endpoints
- Evaluating Candidate Principal Surrogate Endpoints
- Nonparametric causal effects based on marginal structural models
- Statistical Methods for Assessing Differential Vaccine Protection Against Human Immunodeficiency Virus Types
- Design and estimation for evaluating principal surrogate markers in vaccine trials
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model
- Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
- Sieve analysis using the number of infecting pathogens
- A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework
Cited In (7)
- Testing and Estimation of Time‐Varying Cause‐Specific Hazard Ratios with Covariate Adjustment
- Allowing for two different mechanisms by which lesion free lung lobes occur in pigs after an experimental challenge: Vaccine performance comparisons
- Endpoints in vaccine trials
- Causal inference methods for vaccine sieve analysis with effect modification
- Evaluation of American strangles
- COMPARATIVE DYNAMICS OF MONOVALENT AND BIVALENT VACCINATION FOR IMMUNOLOGICALLY UNRELATED PATHOGENS
- Chop-Lump Tests for Vaccine Trials
This page was built for publication: A unified evaluation of differential vaccine efficacy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6047741)
